<DOC>
	<DOCNO>NCT03099616</DOCNO>
	<brief_summary>Complete recovery anaesthesia absolutely desirable obese patient avoid postoperative airway , oxygen ventilation sleep apnea related complication . Over year , Desflurane emerge anaesthetic agent choice maintenance anaesthesia obese patient efficient elimination profile ability facilitate early recovery anaesthesia . Alternatively , Propofol commonly use intravenous anesthetic agent administer part total intravenous anesthesia ( TIVA ) regimen . However , lipid soluble drug concern may accumulate obese patient due increase proportion body fat Therefore , Propofol TIVA likely result prolong duration action consequently , delay emergence anaesthesia protract recovery time . A recent advance delivery Propofol patient development computer-controlled anesthesia delivery system . These device deliver Propofol base feedback patient 's frontal cortex electrical activity determine monitor bispectral index ( BIS ) . Evaluation anesthesia delivery system show Propofol maintain depth anesthesia far precision compare manual/simple infusion administration . This , turn , hold promise recovery Propofol anaesthesia also favourable obese patient . An indigenously developed computer-controlled anesthesia delivery sytem close loop anaesthesia delivery system ( CLADS ) , extensively evaluated patient belong different surgical setting . The evidence generate Propofol anaesthesia deliver CLADS show significant improvement recovery outcome.The performance CLADS yet evaluate obese surgical patient . We hypothesise obese patient undergo bariatric surgery , automate delivery Propofol use CLADS would allow precision control anaesthesia depth , intra-operative haemodynamics , rapid recovery anaesthesia . We plan conduct randomise controlled investigation compare patient recovery profile follow Desflurane anaesthesia versus CLADS empower Propofol anaesthesia .</brief_summary>
	<brief_title>Automated Closed Loop Propofol Anaesthesia Versus Desflurane Inhalation Anaesthesia In Bariatric Surgery</brief_title>
	<detailed_description>After Institutional Ethics Committee approval write informed consent , forty-participants ( 20 per group ) age 18-65 year , ASA physical status I/III , BMI &gt; 35-kg/m2 , either sex , undergo laparoscopic/robotic bariatric surgery ( sleeve gastrectomy gastric bypass ) include single center ( Sir Ganga Ram Hospital , New Delhi-110060 , India ) prospective , double-blinded , two-arm , randomise control study . The patient qualify inclusion criterion consent recruitment randomly divide one two group : Group-1 [ CLADS Group , n=20 ] : Anaesthesia induce maintain Propofol administer use automate CLADS . Group-2 [ Desflurane Group , n=20 ] : Anaesthesia induce Propofol administer use automate CLADS maintain Desflurane . Sample-size Estimation In previous study , time-to-eye opening Desflurane Propofol 4.2 minute 10.7 minute , respectively . Based , sample size 15-patients require per group provide 90 % power bilateral α-risk value 0.05 posit significant difference time-to-eye opening . We plan recruit total 40-patients cover unanticipated loss recruitment . Randomization , Allocation Concealment The patient randomly allocate one two group base computer-generated random number table ( url : stattrek.com/statistics/random-number-generator.aspx ) . Randomization sequence concealment include opaque-sealed envelope alphabetic code whose distribution control independent analyst . The envelope open ; patient 's data-slip paste , send back control analyst . Blinding Strategy The attend anaesthesiologist blind technique utilized administer GA recovery immediately extubation inside OR . However , postoperative patient recovery profile evaluate independent assessor blind technique GA. Management Anesthesia Two peripheral venous line ( 18G/20G catheter ) secure . Standard monitoring ( EKG , NIBP , pulse oximeter , EtCO2 ) apply . A BIS sensor ( Covidien IIc , Mansfield , USA ) apply patient 's forehead accord manufacturer 's instruction prior induction anaesthesia monitor depth anaesthesia . The BIS monitoring module ( Model DSC-XP , Aspect medical system , USA ) facilitate monitor anaesthesia depth . Anaesthesia Technique All patient administer pre-induction fentanyl-citrate analgesia per predefined strategy ( total 2-µg/kg IV : 1-µg/kg 0 minute 3-minute time point ) . Pre-oxygenation initiated 3-minute time point prior fall oxygen saturation ( &lt; 94 percent ) . In group , 6-minute time point , anesthesia induce Propofol administer CLADS . In group CLADS set deliver Propofol accord lean body weight ( LBW ) . A BIS-value 50 use target induction anesthesia . After induction anesthesia , atracurium besylate 0.05-mg/kg administer skeletal muscle relaxation facilitate tracheal intubation . Ventilator setting CMV , tracheal tube size [ 7.5-mm I.D ( male ) , 6.5-mm I.D ( female ) ] , breathe circuit ( circle-CO2 absorber system ) standardize patient . Thereafter , patient CLADS group receive anaesthesia maintenance Propofol , dose base adjust body weight ( ABW ) , administration control CLADS tune consistent anaesthetic depth ( BIS-50 ) feedback patient . The patient Desflurane group receive anaesthesia maintenance Desflurane dial concentration titrate maintain BIS 50-55 patient . Oxygen-air mixture ( FiO2 0.50 ) use ventilation group . In addition , start post-intubation , patient receive 1.0-µg/kg/hr fentanyl infusion intraoperative analgesia . Intraoperative muscle relaxation maintain use atracurium bolus control train-of-four response peripheral neuromuscular monitor ( Infinity TridentNMT Smartpod , Draeger Medical Systems , Inc Telford , USA ) . Thirty minute end surgery , non-opioid analgesic , paracetamol 1-gm , tramadol 100-mg administered patient . The Propofol Desflurane delivery stop point completion skin closure . Residual neuromuscular blockade ( assessed train-of-four response ) reverse neostigmine ( 50-µg/kg ) glycopyrrolate ( 20-µg/kg ) . Thirty minute end surgery , non-opioid analgesic , paracetamol 1-gm , tramadol 100-mg administered patient . The Propofol Desflurane delivery stop point completion skin closure . Residual neuromuscular blockade ( assessed train-of-four response ) reverse neostigmine ( 50-µg/kg ) glycopyrrolate ( 20-µg/kg ) .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Desflurane</mesh_term>
	<mesh_term>Isoflurane</mesh_term>
	<criteria>Patients age 1860 year BMI &gt; 35 kg/m2 Either sex ASA physical status II &amp; III Undergoing laparoscopic/ robotic bariatric surgery Uncompensated cardiovascular disease ( e.g . uncontrolled hypertension , atrioventricular block , sinus bradycardia , congenital heart disease , reduce LV compliance , diastolic dysfunction ) Hepatorenal insufficiency Uncontrolled endocrinology disease ( e.g . diabetes mellitus , hypothyroidism ) Known allergy/hypersensitivity study drug Pulmonary dysfunction ( obstructive/restrictive lung disease ) Acute/chronic drug dependence/substance abuse Requirement postoperative ventilation Refusal inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>propofol</keyword>
	<keyword>CLADS</keyword>
	<keyword>Desflurane</keyword>
	<keyword>Obesity</keyword>
</DOC>